0000899243-21-037904.txt : 20210927
0000899243-21-037904.hdr.sgml : 20210927
20210927212638
ACCESSION NUMBER: 0000899243-21-037904
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210923
FILED AS OF DATE: 20210927
DATE AS OF CHANGE: 20210927
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Naydenov Jordan G
CENTRAL INDEX KEY: 0001469618
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-49908
FILM NUMBER: 211283347
MAIL ADDRESS:
STREET 1: 1111 MAIN STREET, SUITE 660
CITY: VANCOUVER
STATE: WA
ZIP: 98660
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CytoDyn Inc.
CENTRAL INDEX KEY: 0001175680
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 753056237
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0531
BUSINESS ADDRESS:
STREET 1: 1111 MAIN STREET, SUITE 660
CITY: VANCOUVER
STATE: WA
ZIP: 98660
BUSINESS PHONE: 360-980-8524
MAIL ADDRESS:
STREET 1: 1111 MAIN STREET, SUITE 660
CITY: VANCOUVER
STATE: WA
ZIP: 98660
FORMER COMPANY:
FORMER CONFORMED NAME: CYTODYN INC
DATE OF NAME CHANGE: 20031114
FORMER COMPANY:
FORMER CONFORMED NAME: REXRAY CORP
DATE OF NAME CHANGE: 20020617
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-09-23
0
0001175680
CytoDyn Inc.
CYDY
0001469618
Naydenov Jordan G
1111 MAIN STREET, SUITE 660
VANCOUVER
WA
98660
1
0
0
0
Common Stock
2021-09-23
4
M
0
888888
0.45
A
7590211
D
Common Stock
2021-09-23
4
M
0
133332
0.75
A
7723543
D
Common Stock
2021-09-23
4
M
0
266668
0.75
A
7990211
D
Warrant (Right to Buy)
0.45
2021-09-23
4
D
0
444444
D
2019-12-13
2024-12-13
Common Stock
444444
0
D
Warrant (Right to Buy)
0.75
2021-09-23
4
D
0
66666
D
2017-07-26
2022-07-26
Common Stock
66666
0
D
Warrant (Right to Buy)
0.75
2021-09-23
4
D
0
133334
D
2018-01-31
2023-01-31
Common Stock
133334
0
D
Warrant (Right to Buy)
0.45
2021-09-23
4
A
0
888888
A
2021-09-23
2024-12-13
Common Stock
888888
888888
D
Warrant (Right to Buy)
0.75
2021-09-23
4
A
0
133332
A
2021-09-23
2022-07-26
Common Stock
133332
133332
D
Warrant (Right to Buy)
0.75
2021-09-23
4
A
0
266668
A
2021-09-23
2023-01-31
Common Stock
266668
266668
D
Warrant (Right to Buy)
0.45
2021-09-23
4
M
0
888888
D
2021-09-23
2024-12-13
Common Stock
888888
0
D
Warrant (Right to Buy)
0.75
2021-09-23
4
M
0
133332
D
2021-09-23
2022-07-26
Common Stock
133332
0
D
Warrant (Right to Buy)
0.75
2021-09-23
4
M
0
266668
D
2021-09-23
2023-01-31
Common Stock
266668
0
D
On September 23, 2021, as an inducement to exercise, the Issuer and the Reporting Person agreed to amend three warrants held by the Reporting Person (the "Warrants") to purchase a total of 644,444 shares of the Issuer's common stock, par value $0.001 per share (the "Common Stock"), pursuant to which twice as many shares could be purchased for double the total original exercise price.
By: /s/ Michael D. Mulholland, Attorney-in-fact
2021-09-27